View in EDS

PMS52 Validation of Remission of Rheumatoid Arthritis by Traditional Disease Activity Score and Provisional Criteria by American College of Rheumatology and European League Agaisnt Rheumatism: Analysis Based on Patient Reported Outcomes from 3 Phase III Clinical Trials of Golimumab

Saved in:
Bibliographic Details
Title: PMS52 Validation of Remission of Rheumatoid Arthritis by Traditional Disease Activity Score and Provisional Criteria by American College of Rheumatology and European League Agaisnt Rheumatism: Analysis Based on Patient Reported Outcomes from 3 Phase III Clinical Trials of Golimumab
Authors: Han, C.1, Keystone, E.2, Fleischmann, R.3, Smolen, J.S.4, Emery, P.5, Genovese, M.6, Doyle, M.7, Hsia, E.7
Source: Value in Health. pA43-A43. 1p.
Database: Academic Search Ultimate
Description
ISSN:10983015
DOI:10.1016/j.jval.2012.03.241